Abingdon Health Plc

Equities

ABDX

GB00BLF79J41

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 11:35:05 2024-04-30 am EDT			5-day change	1st Jan Change
10 ^GBX	0.00%		-4.76%	-9.09%

Mar. 25	Peel Hunt's RetailBook raises GBP2.5 million	AN
Mar. 25	Abingdon Health Completes Design Freeze for STD Self-Tests	MT

Abingdon Health plc Provides Earnings Guidance for the Second Half and Full Fiscal Year 2024

March 14, 2024 at 03:00 am EDT

Abingdon Health plc provided earnings guidance for the second half and full fiscal year 2024. For the second half, the company expects revenue will be significantly improved compared with first half of 2024.

For full fiscal year, the company expects revenue to be materially higher than fiscal year 2023 revenues of £4.0 million.

Latest news about Abingdon Health Plc

Peel Hunt's RetailBook raises GBP2.5 million	Mar. 25	AN
Abingdon Health Completes Design Freeze for STD Self-Tests	Mar. 25	MT
Abingdon Health to Provide Rapid Self-tests to Boots	Mar. 20	MT
Abingdon Health strikes deal amidst upswing in self testing market	Mar. 20	AN
AIM WINNERS & LOSERS: Abingdon Health rises on Boots agreement	Mar. 20	AN
EARNINGS AND TRADING: Smarttech247 and Beeks in deal boosts	Mar. 14	AN
AIM WINNERS & LOSERS: Smartspace backs Sign In bid; Abingdon jumps	Mar. 14	AN
London stocks tread water with US data to come	Mar. 14	AN
ABINGDON HEALTH PLC: BOARD EXPECTS THAT H2 REVENUE WILL BE SIGN…	Mar. 14	RE
Abingdon Health plc Provides Earnings Guidance for the Second Half and Full Fiscal Year 2024	Mar. 14	CI
Abingdon Health Plc Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 14	CI
Abingdon Health shares down despite decent interim results	Jan. 11	AN
Abingdon Health Plc Announces Promotion of Laura Towse as Group Financial Controller	Jan. 11	CI
Abingdon Health plc Announces Resignation of Andrew Feather as Interim Finance Director	Jan. 11	CI
Abingdon Health Plc Reports Revenue Results for the Six Months Ended December 31, 2023	Jan. 11	CI
Abingdon expects higher half-year revenue	Dec. 15	AN
Stocks edge higher ahead of slew of PMIs	Dec. 15	AN
FTSE 100 Closes Up on Tech Earnings Expectations, Easing Bond Yields	23-10-24	DJ
Abingdon Health appoints Feather as new interim finance director	23-10-24	AN
Abingdon Health Names Interim Finance Director	23-10-24	MT
Abingdon Health Plc Announces Executive Changes	23-10-24	CI
FTSE 100 Closes Down 1.1% on Middle East Tensions	23-10-18	DJ
Abingdon Health finance chief resigns, seeks interim hire	23-10-18	AN
Abingdon Health CFO Plans Exit; Stock Drops	23-10-18	MT
Abingdon Health plc Announces Resignation of Melanie Ross as Director	23-10-18	CI

Chart Abingdon Health Plc

Duration

Period

More charts

Company Profile

Abingdon Health plc is a lateral flow contract development and manufacturing organization (CDMO). The Company develops, manufactures, and distributes diagnostic devices and provides consultancy services to businesses in the diagnostics sector. Its segments include Product sales, Contract manufacturing, and Contract development. Its customer base across industry sectors includes clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to enable consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-11-13 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
ABINGDON HEALTH PLC	-9.09%	38.65M
BIOMÉRIEUX	-0.60%	12.95B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.84B
DIASORIN S.P.A.	+1.82%	5.5B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.61B
LANTHEUS HOLDINGS, INC.	+7.34%	4.61B
10X GENOMICS, INC.	-47.96%	3.4B
ANDON HEALTH CO., LTD.	+6.42%	2.66B
VITROLIFE AB	-14.59%	2.08B
MYRIAD GENETICS, INC.	+1.57%	1.79B

Diagnostic & Testing Substances